Welcome to a comprehensive guide on fundamental nursing topics, designed for easy learning and practical application. This guide breaks down essential concepts section by section with explanations, examples, and key points, focusing on providing practical knowledge and actionable steps you can use in your nursing practice.
Table of Contents:
- I. Vital Signs
- II. Hygiene
- III. Nutrition
- IV. Elimination
- V. Medication Administration
- VI. Mobility and Immobility
- VII. Wound Care
- Key Considerations
I. Vital Signs
Vital signs are the cornerstone of patient assessment. They provide a quick snapshot of the patient’s physiological status.
What are Vital Signs?
Temperature, pulse, respiration, blood pressure, and pain (often considered the “fifth vital sign”). Some facilities are beginning to include oxygen saturation as a standard vital sign as well.
Normal Ranges (Adults)
These are general ranges, and variations can occur based on age, health status, and individual circumstances. Always check your facility’s specific guidelines.
Vital Sign | Normal Range |
---|---|
Temperature (Rectal) | 98.6°F – 100.6°F (37°C – 38.1°C) – Generally 1 degree higher than oral |
Temperature (Oral) | 97.6°F – 99.6°F (36.4°C – 37.5°C) |
Temperature (Axillary) | 96.6°F – 98.6°F (35.9°C – 37°C) – Generally 1 degree lower than oral |
Temperature (Tympanic) | Similar to oral, but can be affected by earwax, placement, or improper technique |
Temperature (Temporal Artery) | Similar to oral |
Pulse (Heart Rate) | 60-100 beats per minute (bpm) |
Respirations | 12-20 breaths per minute |
Blood Pressure | Systolic <120 mmHg and Diastolic <80 mmHg |
Oxygen Saturation (SpO2) | 95-100% on room air (RA). Acceptable ranges may vary based on patient condition, such as COPD, where lower O2 sats can be normal |
How to Assess Accurately:
Temperature:
Temperature Measurement Method | Placement Instructions | Duration |
---|---|---|
Oral | Place under the tongue in the posterior sublingual pocket | About 1 minute (or until the device beeps) |
Rectal | Lubricate and insert 1-1.5 inches (adults) | About 2 minutes (or as per thermometer instructions) |
Axillary (Armpit) | Place in the dry axilla with the arm pressed against the body | 4-5 minutes (mercury) or until digital thermometer beeps |
Tympanic (Ear) | Pull the ear up and back (adults) or down and back (children under 3), ensure a tight seal | Few seconds (Instant Read) |
Temporal Artery (Forehead) | Scan from the center of the forehead to the temporal artery | Few seconds (Instant Read) |
Pulse:
Radial: Use your index and middle fingers (never thumb!) to palpate the radial artery (thumb side of the wrist). Count for 30 seconds and multiply by 2 (for regular rhythms). If irregular, count for a full minute. Assess rate, rhythm (regular or irregular), and strength (bounding, strong, weak, thready).
Apical: Use a stethoscope and listen at the apex of the heart (5th intercostal space, midclavicular line) for a full minute. This is the most accurate method for assessing heart rate.
Respirations:
Observe chest rise and fall. Count for 30 seconds and multiply by 2 (for regular rhythms). If irregular, count for a full minute. Assess rate, depth (shallow, normal, deep), and rhythm (regular or irregular). Note any accessory muscle use or labored breathing.
Blood Pressure:
Use the correct cuff size (width should be about 40% of the arm circumference). Position the arm at heart level. Place the stethoscope over the brachial artery. Inflate the cuff to about 20-30 mmHg above the point where the pulse disappears. Slowly release the pressure (2-3 mmHg per second). The first Korotkoff sound is the systolic pressure, and the last is the diastolic pressure. Avoid taking BP on an arm with an IV, PICC line, mastectomy, or AV fistula.
Oxygen Saturation:
Apply the pulse oximeter probe to a finger, toe, earlobe, or nose. Ensure good circulation to the site. Factors like nail polish, cold extremities, and poor circulation can affect accuracy.
Factors Affecting Readings:
Temperature:
Exercise, time of day (lower in the morning), hormones (menstrual cycle), illness, environment, age.
Pulse:
Exercise, stress, anxiety, medications, caffeine, fever, pain, dehydration.
Respirations:
Exercise, anxiety, pain, respiratory conditions, medications, body position.
Blood Pressure:
Age, weight, stress, medications, caffeine, smoking, exercise, time of day, race, family history.
Oxygen Saturation:
Altitude, lung disease, anemia, cold extremities, poor circulation.
Interventions for Abnormal Values:
Condition | Types | Range (BP, HR, Blood Sugar) |
---|---|---|
Hypertension (High BP) | Elevated BP | 120–129 / <80 mmHg |
Stage 1 Hypertension | 130–139 / 80–89 mmHg | |
Stage 2 Hypertension | ≥140 / ≥90 mmHg | |
Hypertensive Crisis | ≥180 / ≥120 mmHg (Emergency) | |
Hypotension (Low BP) | Mild Hypotension | 90–99 / 60–69 mmHg |
Moderate Hypotension | 70–89 / 40–59 mmHg | |
Severe Hypotension (Shock) | <70 / <40 mmHg | |
Tachycardia (High HR) | Mild Tachycardia | 100–120 bpm |
Moderate Tachycardia | 121–150 bpm | |
Severe Tachycardia | >150 bpm (Emergency) | |
Bradycardia (Low HR) | Mild Bradycardia | 50–59 bpm |
Moderate Bradycardia | 40–49 bpm | |
Severe Bradycardia | <40 bpm (May require pacemaker) | |
Hyperglycemia (High Blood Sugar) | Mild Hyperglycemia | 140–199 mg/dL (Postprandial) |
Diabetes (Fasting Glucose) | ≥126 mg/dL | |
Severe Hyperglycemia (DKA) | >250 mg/dL (Emergency) | |
Hypoglycemia (Low Blood Sugar) | Mild Hypoglycemia | 60–70 mg/dL |
Moderate Hypoglycemia | 40–59 mg/dL | |
Severe Hypoglycemia | <40 mg/dL (Life-threatening) |
1. Hypertension (High Blood Pressure)
- Types:
- Primary (Essential): No identifiable cause (90-95% of cases).
- Secondary: Caused by underlying conditions (kidney disease, endocrine disorders, etc.).
- Ranges (mmHg):
- Normal: <120/80
- Elevated: 120-129/<80
- Stage 1 Hypertension: 130-139/80-89
- Stage 2 Hypertension: ≥140/≥90
- Hypertensive Crisis: >180/>120
- Relevant Details:
- “White coat hypertension” can occur in clinical settings.
- Lifestyle modifications (diet, exercise) are essential.
- Monitor for target organ damage (kidneys, heart, brain).
2. Hypotension (Low Blood Pressure)
- Ranges (mmHg):
- Generally <90/60
- Relevant Details:
- Causes: Dehydration, medications, heart problems, etc.
- Symptoms: Dizziness, lightheadedness, blurred vision.
- Monitor for orthostatic hypotension (BP drop upon standing).
3. Tachycardia (Fast Heart Rate)
- Range (bpm):
- >100 (adults)
- Relevant Details:
- Causes: Anxiety, fever, dehydration, etc.
- Monitor ECG for arrhythmias.
4. Bradycardia (Slow Heart Rate)
Pacing may be needed if symptomatic.
Range (bpm):
<60 (adults)
Relevant Details:
Causes: Medications, electrolyte imbalances, etc.
Monitor ECG for arrhythmias.
Fever (Elevated Temperature):
Administer antipyretics (e.g., acetaminophen, ibuprofen) as prescribed.
Encourage fluids.
Apply cooling measures: cool compresses, tepid sponge bath (avoid shivering).
Monitor for signs of infection.
Routes for Temperature Taking and Contraindications:
Route | Advantages | Disadvantages | Contraindications |
---|---|---|---|
Oral | Easy, convenient, non-invasive | Affected by eating/drinking, may not be accurate in unconscious patients | Oral surgery, seizures, confused patients, infants, uncooperative patients, recent oral intake. |
Rectal | Most accurate | Invasive, uncomfortable, time consuming, risk of perforation | Recent rectal surgery, diarrhea, bleeding hemorrhoids, neutropenia (low WBC count). |
Axillary | Non-invasive, safe | Least accurate, affected by sweating | Requires longer time, not suitable for critically ill patients. |
Tympanic | Quick, easy | Can be affected by earwax, improper technique | Ear infections, ear surgery. |
Temporal | Quick, easy, non-invasive | Can be affected by sweating | Scarring on forehead. |
II. Hygiene
Hygiene is essential for maintaining comfort, preventing infection, and promoting overall well-being.
Types of Baths:
- Complete Bed Bath: The nurse performs all aspects of bathing for a patient who is completely dependent.
- Partial Bed Bath: The nurse assists with bathing areas the patient cannot reach (e.g., back, legs, feet). The patient washes the areas they can reach (e.g., face, arms, chest).
- Sitz Bath: Cleanses the perineal area, promotes healing after childbirth or rectal surgery. Involves sitting in a tub or basin of warm water.
- Shower/Tub Bath: Patient washes themselves in a shower or tub, with assistance as needed. Requires the patient to be ambulatory and stable.
- Towel Bath/Bag Bath: Uses pre-moistened cloths to cleanse the skin. Useful for patients who are bedridden or have sensitive skin.
Oral Hygiene:
- Conscious Patient: Encourage brushing teeth at least twice a day with a soft-bristled toothbrush. Provide mouthwash (alcohol-free is preferred). Floss daily.
- Unconscious Patient: Position the patient on their side to prevent aspiration. Use a padded tongue blade to gently open the mouth. Clean the teeth and gums with a toothbrush or foam swab moistened with water or a special mouthwash. Use suction to remove secretions.
- Dentures: Clean dentures daily with denture cleaner and a denture brush. Store dentures in water when not in use to prevent drying and cracking.
Skin Care:
Assess skin daily: Look for redness, dryness, breaks in the skin, or signs of infection.
Keep skin clean and dry: Use mild soap and water. Pat skin dry, avoid rubbing.
Apply moisturizers: Especially after bathing, to prevent dryness and cracking.
Avoid harsh chemicals or irritants: Use fragrance-free products.
Protect skin from friction and shear: Use barrier creams, protective dressings, and proper positioning techniques.
Pressure Ulcer Prevention:
Risk Assessment: Use a validated tool like the Braden Scale to assess risk factors for pressure ulcers (mobility, sensory perception, moisture, activity, nutrition, friction/shear).
Repositioning: Turn and reposition patients at least every 2 hours. Use pillows or foam wedges to relieve pressure points.
Pressure-Relieving Devices: Use specialized mattresses, cushions, and heel protectors to reduce pressure.
Skin Care: Keep skin clean and dry. Apply barrier creams to protect against moisture.
Nutrition: Ensure adequate protein and calorie intake to promote skin health and healing.
Hydration: Maintain adequate hydration to keep skin supple.
Pressure Ulcer Staging:
Stage 1: Non-blanchable erythema (redness) of intact skin. Skin is intact.
Stage 2: Partial-thickness skin loss involving the epidermis or dermis. Presents as a shallow open ulcer with a red-pink wound bed, without slough. May also present as an intact or ruptured serum-filled blister.
Stage 3: Full-thickness skin loss involving damage or necrosis of subcutaneous tissue. The ulcer presents as a deep crater with or without undermining of adjacent tissue. Slough may be present but does not obscure the depth of tissue loss.
Stage 4: Full-thickness tissue loss with exposed bone, tendon, or muscle. Slough or eschar may be present. Often includes undermining and tunneling.
Unstageable: Full-thickness tissue loss in which the base of the ulcer is covered by slough (yellow, tan, gray, green, or brown) and/or eschar (tan, brown, or black) in the wound bed.
Deep Tissue Injury (DTI): Purple or maroon localized area of discolored intact skin or blood-filled blister due to damage of underlying soft tissue from pressure and/or shear. The area may be painful, firm, mushy, boggy, warmer, or cooler as compared to adjacent tissue.
Interventions for Pressure Ulcers (Based on Stage):
Stage 1: Relieve pressure, keep skin clean and dry, apply barrier cream, monitor for progression.
Stage 2: Cleanse with normal saline, apply moisture-retentive dressing (hydrocolloid, transparent film), protect surrounding skin.
Stage 3: Debridement (removal of necrotic tissue), wound packing, moisture-retentive dressing, consider negative pressure wound therapy (wound vac).
Stage 4: Debridement, wound packing, consider surgical intervention (flap closure), negative pressure wound therapy.
Unstageable: Debride the wound to expose the base and stage accurately.
DTI: Relieve pressure, protect the area, monitor closely for progression.
Infection Control Practices:
Hand Hygiene: The most important measure to prevent the spread of infection. Wash hands with soap and water for at least 20 seconds, or use an alcohol-based hand sanitizer.
Personal Protective Equipment (PPE): Use gloves, gowns, masks, and eye protection as needed to protect yourself and your patients from exposure to infectious agents.
Standard Precautions: Treat all patients as if they are potentially infectious. Use hand hygiene and PPE when indicated.
Transmission-Based Precautions: Used in addition to standard precautions when a patient has a known or suspected infection. Include contact precautions, droplet precautions, and airborne precautions.
Isolation: Place patients with highly contagious infections in a private room to prevent transmission.
Proper Disposal of Sharps: Use sharps containers to dispose of needles, syringes, and other sharp objects.
Cleaning and Disinfection: Clean and disinfect equipment and surfaces regularly.
Sterilization: Sterilize critical equipment that comes into contact with sterile body tissues.
Go to Table of Contents Quickly
III. Nutrition
Nutrition is essential for maintaining health, promoting healing, and preventing complications.
Basic Nutritional Needs:
Macronutrients:
- Carbohydrates: Provide energy. Sources include bread, pasta, rice, fruits, and vegetables.
- Proteins: Build and repair tissues. Sources include meat, poultry, fish, eggs, dairy products, beans, and nuts.
- Fats: Provide energy, insulate the body, and protect organs. Sources include oils, butter, avocados, nuts, and seeds.
Micronutrients:
Vitamins: Essential for various bodily functions.
Minerals: Essential for bone health, nerve function, and other processes.
Water:
Essential for hydration, nutrient transport, and waste removal.
Therapeutic Diets:
Diabetic Diet: Controlled carbohydrate intake, focus on whole grains, lean protein, healthy fats, and plenty of fruits and vegetables. Goal is to maintain stable blood sugar levels.
Low-Sodium Diet: Restricts sodium intake to manage hypertension, heart failure, and kidney disease. Avoid processed foods, canned goods, and salty snacks.
Low-Fat Diet: Restricts fat intake to manage heart disease, gallbladder disease, and other conditions. Focus on lean protein, fruits, vegetables, and whole grains.
Renal Diet: Restricts protein, sodium, potassium, and phosphorus to manage kidney disease.
Cardiac Diet: Low in saturated fat, cholesterol, and sodium. Focus on lean protein, fruits, vegetables, and whole grains.
Clear Liquid Diet: Provides fluids and electrolytes. Includes clear broths, gelatin, clear juices, and popsicles. Used for short-term bowel rest or pre-operative preparation.
Full Liquid Diet: Includes clear liquids plus milk, yogurt, creamed soups, and ice cream. Used as a transition diet after clear liquids.
Mechanical Soft Diet: Foods that are easy to chew and swallow. Includes mashed potatoes, pureed foods, soft fruits, and cooked vegetables.
Feeding Techniques (Dysphagia & Altered Consciousness):
Dysphagia (Difficulty Swallowing):
Position the patient upright (90 degrees) during and after meals.
Provide small, frequent meals.
Thicken liquids to the appropriate consistency (nectar-thick, honey-thick, pudding-thick).
Encourage the patient to tuck their chin to their chest during swallowing.
Monitor for coughing, choking, or wet vocal quality.
Consult with a speech therapist for a swallow evaluation.
Altered Consciousness:
Assess the patient’s ability to swallow before feeding.
Consider alternative feeding methods, such as a nasogastric tube (NG tube), gastrostomy tube (G-tube), or jejunostomy tube (J-tube).
If oral feeding is attempted, position the patient on their side and use a small amount of food at a time.
Monitor for aspiration.
Monitoring Intake and Output (I&O):
Intake: Measure all fluids consumed by the patient, including oral fluids, IV fluids, tube feedings, and medications.
Output: Measure all fluids excreted by the patient, including urine, stool, emesis, wound drainage, and drainage from tubes.
Document I&O accurately: Record the amount and type of fluid in the patient’s chart.
Compare intake and output: Assess for fluid imbalances (fluid overload or dehydration).
Report significant changes in I&O: To the physician or other healthcare provider.
Go to Table of Contents Quickly
Color Code | Waste Type | Examples (as per Image/Modified) |
---|---|---|
Red Bags | Plastics waste | Catheters, injections, syringes, tubings I.V., bottles. |
Blue Bags | Glass and Discarded Medicines | All types of glass bottles and articles, outdated & discarded medicines. |
Yellow Bags | Infectious Waste and Human/Animal Waste | Bandages, gauzes, cotton, body fluids, human body parts, placenta. |
Black Bags | General Waste | Wrappers, food stuff, paper. |
White Containers | Sharps Disposal | Needles, syringes, blades, broken ampules. |
IV. Elimination
Elimination refers to the excretion of waste products from the body.
Bowel and Bladder Elimination Patterns:
Normal Bowel Patterns: Vary depending on individual factors, such as diet, fluid intake, activity level, and medications. Normal stool is brown, formed, and passed without difficulty.
Normal Bladder Patterns: Most adults void 5-6 times per day. Normal urine is clear, yellow, and has a characteristic odor.
Assess: Frequency, color, consistency, amount, odor, and any associated symptoms (pain, straining, urgency).
Catheter Care:
Insertion: Requires sterile technique. Use the correct size catheter. Lubricate the catheter. Insert gently until urine flows. Advance the catheter another 1-2 inches and inflate the balloon.
Maintenance:
Clean the perineal area daily with soap and water.
Keep the catheter drainage bag below the level of the bladder.
Ensure the catheter tubing is free of kinks.
Secure the catheter to the patient’s leg to prevent traction.
Empty the drainage bag regularly.
Removal: Deflate the balloon completely. Gently remove the catheter. Monitor the patient for urinary retention after removal.
Type of Catheter | Size (French Gauge – Fr) | Material | Usage Duration | Common Uses |
---|---|---|---|---|
Foley Catheter (Indwelling) | 12-24 Fr | Latex, Silicone | Short to long-term | Used for patients unable to urinate on their own, post-surgery, or with urinary retention. |
Suprapubic Catheter | 14-24 Fr | Silicone | Long-term | Inserted through the abdominal wall into the bladder, used for chronic urinary retention. |
Intermittent (Robinson) Catheter | 8-18 Fr | Rubber, PVC | Short-term | Used for temporary drainage, self-catheterization, or after surgery. |
External (Condom) Catheter | N/A | Silicone, Latex | Daily replacement | Used for male patients with incontinence to collect urine externally. |
Central Venous Catheter (CVC) | 4-9 Fr | Polyurethane, Silicone | Medium to long-term | Used for chemotherapy, long-term IV therapy, or critical care. |
Hemodialysis Catheter | 10-16 Fr | Polyurethane | Temporary | Used for patients requiring dialysis access for blood filtration. |
PICC Line (Peripherally Inserted Central Catheter) | 4-7 Fr | Polyurethane, Silicone | Weeks to months | Used for long-term IV therapy, antibiotics, chemotherapy. |
Enemas:
Types:
Cleansing Enemas: Stimulate bowel evacuation. Include tap water enemas, saline enemas, soap suds enemas, and hypertonic enemas (Fleet enema).
Retention Enemas: Retained in the bowel for a period of time. Include oil retention enemas (lubricate the stool) and medicated enemas.
Administration: Position the patient on their left side (Sims’ position). Lubricate the enema tip. Insert the tip gently into the rectum (3-4 inches in adults). Slowly instill the solution. Encourage the patient to retain the solution for the prescribed amount of time.
Management of Incontinence:
Urinary Incontinence:
Types: Stress incontinence, urge incontinence, overflow incontinence, functional incontinence.
Interventions: Pelvic floor exercises (Kegel exercises), bladder training, scheduled voiding, medications (anticholinergics), absorbent products, intermittent catheterization, surgical interventions.
Fecal Incontinence:
Interventions: Bowel training, dietary modifications (increase fiber), medications (antidiarrheals or stool softeners), absorbent products, skin care, surgical interventions.
Go to Table of Contents Quickly
V. Medication Administration
Safe medication administration is a critical nursing responsibility.
The “Rights” of Medication Administration:
Right Patient: Verify the patient’s identity using two identifiers (name, date of birth, medical record number).
Right Medication: Check the medication order and the medication label carefully.
Right Dose: Calculate the correct dose. Double-check calculations with another nurse.
Right Route: Administer the medication by the prescribed route.
Right Time: Administer the medication at the correct time.
Right Documentation: Document the medication administration immediately after giving it.
Right Reason: Know why the patient is receiving the medication.
Right Response: Monitor patient closely: For signs and symptoms of adverse reactions.
Go to Table of Contents Quickly
Patient Rights | Description |
---|---|
Right to Informed Consent | Patients have the right to be fully informed about their medical condition, treatment options, risks, and benefits before making decisions. |
Right to Privacy and Confidentiality | Personal health information must be kept private, and medical records should only be shared with authorized individuals. |
Right to Respect and Dignity | Patients must be treated with respect, regardless of their background, ethnicity, religion, or financial status. |
Right to Access Medical Records | Patients have the right to view and obtain copies of their medical records upon request. |
Right to Participate in Decision-Making | Patients can take part in planning their healthcare and making choices about treatment options. |
Right to Refuse Treatment | Patients have the right to refuse any medical treatment or procedure, even if it may be life-saving. |
Right to Emergency Care | Every patient has the right to receive emergency medical care, regardless of their ability to pay. |
Right to Pain Management | Patients have the right to appropriate assessment and management of pain. |
Right to Complain | Patients can file complaints about their treatment and care without fear of retaliation. |
Right to Choose a Healthcare Provider | Patients have the right to select their doctors, specialists, and hospitals. |
VI. Mobility and Immobility
Mobility is the ability to move freely and easily. Immobility can lead to numerous complications.
Go to Table of Contents Quickly
VII. Wound Care
Wound care is essential for promoting healing and preventing infection.
Go to Table of Contents Quickly
Type of Cannula | Size (Gauge) | Color Code | Outer Diameter (mm) | Flow Rate (mL/min) | Common Uses |
---|---|---|---|---|---|
Neonatal Cannula | 26G | Purple | 0.45 mm | 13 mL/min | Used for neonates, premature babies, and very fragile veins. |
Pediatric Cannula | 24G | Yellow | 0.56 mm | 20 mL/min | Used in pediatrics, small fragile veins, and elderly patients. |
Small Vein Cannula | 22G | Blue | 0.72 mm | 35 mL/min | Suitable for elderly patients, antibiotics, and long-term medications. |
Standard IV Cannula | 20G | Pink | 0.90 mm | 65 mL/min | Used for blood transfusion, IV fluids, and most hospital patients. |
Large Vein Cannula | 18G | Green | 1.30 mm | 105 mL/min | Used in trauma, surgeries, rapid fluid resuscitation, and blood transfusions. |
High Flow Cannula | 16G | Grey | 1.70 mm | 200 mL/min | Used in emergency settings, surgery, and massive blood transfusion. |
Massive Transfusion Cannula | 14G | Orange | 2.10 mm | 300 mL/min | Used for major trauma, emergency resuscitation, and ICU cases. |
Nasal Cannula | N/A | Clear | N/A | Oxygen Flow: 1-6 L/min | Used for oxygen therapy in patients with respiratory distress. |
SN | Drug Name | Dosage (Typical) | Route | Uses (Indications) | Side Effects | Mode of Action | Category |
---|---|---|---|---|---|---|---|
1 | Epinephrine | 0.3-0.5 mg IM/IV | IM/IV | Anaphylaxis, cardiac arrest | Tachycardia, hypertension, anxiety, tremors | Adrenergic agonist (alpha & beta) | Emergency |
2 | Atropine | 0.5 mg IV | IV | Bradycardia, antidote for organophosphate poisoning | Tachycardia, dry mouth, blurred vision, urinary retention | Anticholinergic | Emergency |
3 | Naloxone | 0.4-2 mg IV/IM/IN | IV/IM/IN | Opioid overdose | Nausea, vomiting, withdrawal symptoms, tachycardia | Opioid antagonist | Emergency |
4 | Adenosine | 6-12 mg IV | IV | Supraventricular tachycardia (SVT) | Flushing, chest pain, shortness of breath, bradycardia | Slows conduction through AV node | Emergency |
5 | Amiodarone | 300 mg IV | IV | Ventricular arrhythmias, atrial fibrillation/flutter | Hypotension, bradycardia, QTc prolongation, thyroid dysfunction | Potassium channel blocker, sodium channel blocker, beta-adrenergic blocker | Cardiovascular |
6 | Ceftriaxone | 1-2 g IV/IM | IV/IM | Pneumonia, meningitis, sepsis, gonorrhea | Diarrhea, rash, elevated liver enzymes, allergic reactions | Inhibits bacterial cell wall synthesis (beta-lactam) | Antimicrobial |
7 | Vancomycin | 15-20 mg/kg IV | IV | MRSA, C. difficile (oral) | Nephrotoxicity, ototoxicity, red man syndrome, hypotension | Inhibits bacterial cell wall synthesis (glycopeptide) | Antimicrobial |
8 | Piperacillin/Tazobactam | 3.375-4.5 g IV | IV | Broad-spectrum bacterial infections | Diarrhea, rash, elevated liver enzymes, allergic reactions | Inhibits bacterial cell wall synthesis (beta-lactam/beta-lactamase inhibitor) | Antimicrobial |
9 | Azithromycin | 500 mg PO day 1, 250 mg PO days 2-5 | PO | Community-acquired pneumonia, chlamydia | Nausea, vomiting, diarrhea, abdominal pain, QTc prolongation | Inhibits bacterial protein synthesis (macrolide) | Antimicrobial |
10 | Ciprofloxacin | 400 mg IV/ 500 mg PO | IV/PO | UTI, pneumonia, abdominal infections | Nausea, vomiting, diarrhea, tendon rupture, QTc prolongation | Inhibits bacterial DNA replication (fluoroquinolone) | Antimicrobial |
11 | Morphine | 2-10 mg IV/IM/SC | IV/IM/SC | Moderate to severe pain | Respiratory depression, constipation, nausea, hypotension | Opioid agonist (mu receptor) | Analgesic |
12 | Fentanyl | 25-100 mcg IV/IM | IV/IM | Moderate to severe pain, anesthesia | Respiratory depression, constipation, nausea, hypotension | Opioid agonist (mu receptor) | Analgesic |
13 | Hydromorphone | 0.2-1 mg IV/IM | IV/IM | Moderate to severe pain | Respiratory depression, constipation, nausea, hypotension | Opioid agonist (mu receptor) | Analgesic |
14 | Acetaminophen | 325-650 mg PO q4-6h | PO | Mild to moderate pain, fever | Liver toxicity (with high doses), rash | Inhibits prostaglandin synthesis in CNS | Analgesic |
15 | Ibuprofen | 200-800 mg PO q6-8h | PO | Mild to moderate pain, inflammation, fever | GI upset, renal toxicity, increased bleeding risk | Inhibits prostaglandin synthesis (NSAID) | Analgesic |
16 | Ketorolac | 15-30 mg IV/IM , 10mg PO | IV/IM/PO | Mild to moderate pain, inflammation | GI upset, renal toxicity, increased bleeding risk | Inhibits prostaglandin synthesis (NSAID) | Analgesic |
17 | Metoprolol | 25-100 mg PO BID | PO | Hypertension, angina, heart failure, atrial fibrillation | Bradycardia, hypotension, fatigue, dizziness | Beta-adrenergic blocker (selective beta-1) | Cardiovascular |
18 | Lisinopril | 10-40 mg PO daily | PO | Hypertension, heart failure, post-MI | Hypotension, cough, angioedema, hyperkalemia | ACE inhibitor | Cardiovascular |
19 | Amlodipine | 5-10 mg PO daily | PO | Hypertension, angina | Peripheral edema, headache, flushing, dizziness | Calcium channel blocker (dihydropyridine) | Cardiovascular |
20 | Digoxin | 0.125-0.25 mg PO daily | PO | Heart failure, atrial fibrillation | Bradycardia, nausea, vomiting, visual disturbances, arrhythmias | Inhibits Na+/K+ ATPase, increasing intracellular calcium | Cardiovascular |
21 | Furosemide | 20-80 mg PO/IV daily | PO/IV | Heart failure, edema | Hypokalemia, hypotension, dehydration, ototoxicity | Loop diuretic (inhibits Na+/K+/2Cl- cotransporter) | Cardiovascular |
22 | Atorvastatin | 10-80 mg PO daily | PO | Hyperlipidemia | Myalgia, elevated liver enzymes, rhabdomyolysis | HMG-CoA reductase inhibitor (statin) | Cardiovascular |
23 | Nitroglycerin | 0.4mg sublingual PRN, IV drip | SL, IV | Angina pectoris, hypertensive crisis, heart failure | Headache, hypotension, dizziness, flushing | Vasodilator (converted to nitric oxide, increasing cGMP) | Cardiovascular |
24 | Warfarin | Dosage based on INR | PO | Atrial fibrillation, DVT/PE, prosthetic heart valves | Bleeding, bruising, drug interactions | Vitamin K antagonist (inhibits synthesis of clotting factors) | Anticoagulant |
25 | Heparin | 5000 units SC BID/TID, or IV drip | SC/IV | DVT/PE, acute coronary syndrome | Bleeding, thrombocytopenia (HIT) | Activates antithrombin III, inhibiting clotting factors | Anticoagulant |
26 | Enoxaparin | 1 mg/kg SC BID or 1.5 mg/kg daily | SC | DVT/PE, acute coronary syndrome | Bleeding, thrombocytopenia | Low molecular weight heparin (activates antithrombin III) | Anticoagulant |
27 | Rivaroxaban | 10-20 mg PO daily | PO | Atrial fibrillation, DVT/PE | Bleeding | Factor Xa inhibitor | Anticoagulant |
28 | Apixaban | 2.5-5 mg PO BID | PO | Atrial fibrillation, DVT/PE | Bleeding | Factor Xa inhibitor | Anticoagulant |
29 | Clopidogrel | 75 mg PO daily | PO | Acute Coronary syndrome, after stent placement, secondary prevention of stroke/MI | Bleeding | Inhibits platelet aggregation | Antiplatelet |
30 | Aspirin | 81 mg PO daily | PO | Acute Coronary syndrome, after stent placement, secondary prevention of stroke/MI | Bleeding, GI upset | Inhibits platelet aggregation | Antiplatelet |
31 | Albuterol | 2.5 mg nebulized q4-6h PRN | Neb | Asthma, COPD (bronchospasm) | Tachycardia, tremors, anxiety | Beta-adrenergic agonist (selective beta-2) | Respiratory |
32 | Ipratropium | 500 mcg nebulized q6-8h PRN | Neb | COPD, asthma (bronchospasm) | Dry mouth, blurred vision, urinary retention | Anticholinergic (bronchodilator) | Respiratory |
33 | Fluticasone | 50-250 mcg inhaled BID | Inhaled | Asthma (long-term control) | Oral candidiasis (thrush), hoarseness | Corticosteroid (anti-inflammatory) | Respiratory |
34 | Prednisone | 20-60 mg PO daily | PO | Asthma exacerbation, COPD exacerbation | Elevated blood sugar, mood changes, increased appetite, fluid retention | Corticosteroid (anti-inflammatory) | Respiratory |
35 | Montelukast | 10 mg PO daily | PO | Asthma (long-term control), allergic rhinitis | Headache | Leukotriene receptor antagonist | Respiratory |
36 | Pantoprazole | 40 mg PO/IV daily | PO/IV | GERD, PUD, stress ulcer prophylaxis | Headache, diarrhea, C. difficile infection | Proton pump inhibitor (PPI) | GI |
37 | Ondansetron | 4-8 mg IV/PO q8h PRN | IV/PO | Nausea, vomiting | Headache, constipation, QTc prolongation | Serotonin (5-HT3) receptor antagonist | Gastrointestinal |
38 | Metoclopramide | 5-10 mg IV/PO q8h PRN | IV/PO | Nausea, vomiting, gastroparesis | Drowsiness, extrapyramidal symptoms (EPS), QTc prolongation | Dopamine antagonist (prokinetic) | Gastrointestinal |
39 | Lactulose | 15-30 mL PO daily/BID | PO | Constipation, hepatic encephalopathy | Diarrhea, abdominal cramping | Osmotic laxative, reduces ammonia levels | Gastrointestinal |
40 | Polyethylene Glycol (Miralax) | 17 g PO daily | PO | Constipation | Diarrhea, abdominal cramping | Osmotic laxative | Gastrointestinal |
41 | Haloperidol | 2-5 mg IM/PO q4-8h PRN | IM/PO | Acute psychosis, agitation | Extrapyramidal symptoms (EPS), QTc prolongation, sedation | Dopamine antagonist (typical antipsychotic) | Psychiatric |
42 | Lorazepam | 0.5-2 mg IV/IM/PO q6-8h PRN | IV/IM/PO | Anxiety, agitation, seizures, alcohol withdrawal | Sedation, respiratory depression, hypotension | Benzodiazepine (GABA agonist) | Psychiatric |
43 | Sertraline | 25-200 mg PO daily | PO | Depression, anxiety disorders, OCD | Nausea, diarrhea, sexual dysfunction, insomnia | Selective serotonin reuptake inhibitor (SSRI) | Psychiatric |
44 | Quetiapine | 25-800 mg PO daily/BID | PO | Bipolar disorder, Schizophrenia | Sedation, weight gain, metabolic syndrome | Atypical Antipsychotic (Dopamine antagonist) | Psychiatric |
45 | Trazodone | 50-150 mg PO HS | PO | Insomnia, depression | Sedation, orthostatic hypotension | Serotonin antagonist and reuptake inhibitor (SARI) | Psychiatric |
46 | Insulin Lispro | Dosage varies (SC before meals) | SC | Type 1 and Type 2 Diabetes (mealtime insulin) | Hypoglycemia | Rapid-acting insulin analog | Endocrine |
47 | Insulin Glargine | Dosage varies (SC daily) | SC | Type 1 and Type 2 Diabetes (basal insulin) | Hypoglycemia | Long-acting insulin analog | Endocrine |
48 | Metformin | 500-2000 mg PO daily/BID | PO | Type 2 Diabetes | Nausea, diarrhea, lactic acidosis (rare) | Decreases hepatic glucose production, increases insulin sensitivity | Endocrine |
49 | Levothyroxine | Dosage varies (PO daily) | PO | Hypothyroidism | Tachycardia, anxiety, tremors, heat intolerance | Synthetic T4 (thyroid hormone) | Endocrine |
50 | Dextrose 50% | 25-50 mL IV | IV | Hypoglycemia | Hyperglycemia, tissue necrosis (if extravasation) | Increases blood glucose levels | Endocrine |
51 | Propofol | Dosage varies (IV infusion) | IV | Anesthesia induction and maintenance, sedation | Hypotension, respiratory depression, bradycardia | GABA agonist | Anesthetic |
52 | Midazolam | 1-5 mg IV | IV | Sedation, anxiolysis, anesthesia induction | Respiratory depression, hypotension, amnesia | Benzodiazepine (GABA agonist) | Anesthetic |
53 | Succinylcholine | 1-1.5 mg/kg IV | IV | Rapid sequence intubation (paralysis) | Malignant hyperthermia, hyperkalemia, bradycardia | Depolarizing neuromuscular blocker | MuscleRelaxant |
54 | Rocuronium | 0.6-1.2 mg/kg IV | IV | Paralysis for intubation or surgery | Prolonged paralysis, bradycardia, hypotension | Nondepolarizing neuromuscular blocker | MuscleRelaxant |
55 | Vecuronium | 0.08-0.1 mg/kg IV | IV | Paralysis for intubation or surgery | Prolonged paralysis, bradycardia, hypotension | Nondepolarizing neuromuscular blocker | MuscleRelaxant |
56 | Potassium Chloride | Dosage varies (PO/IV) | PO/IV | Hypokalemia | Hyperkalemia, cardiac arrhythmias, infusion site pain | Replaces potassium deficiency | Electrolyte |
57 | Magnesium Sulfate | Dosage varies (IV/IM) | IV/IM | Hypomagnesemia, pre-eclampsia/eclampsia, torsades de pointes | Hypotension, respiratory depression, decreased reflexes | Replaces magnesium deficiency, CNS depressant | Electrolyte |
58 | Calcium Gluconate | Dosage varies (IV) | IV | Hypocalcemia, hyperkalemia, hypermagnesemia | Hypotension, bradycardia, decreased reflexes | Replaces calcium deficiency | Electrolyte |
59 | Famotidine | 20mg IV/PO BID | IV/PO | Stress Ulcer prophylaxis | Headache, dizziness | H2 receptor antagonist | GI |
60 | Promethazine | 12.5-25 mg IV/IM/PO q4-6h PRN | IV/IM/PO | Nausea, vomiting, Allergic reaction | Sedation, Extrapyramidal symptoms (EPS), tissue necrosis | H1 receptor antagonist | GI |
61 | Diphenhydramine | 25-50 mg IV/IM/PO q4-6h PRN | IV/IM/PO | Allergic reaction, Insomnia | Sedation, dizziness | H1 receptor antagonist | Antihistamine |
62 | Docusate | 100 mg PO Daily | PO | Constipation | Abdominal cramping, Diarrhea | Stool Softener | GI |
63 | Polyethylene Glycol (GoLYTELY) | 4L solution, given PO or via NG tube | PO | Bowel prep prior to procedure | Abdominal cramping, bloating, nausea, vomiting | Osmotic agent | GI |
64 | Labetalol | 20 mg IVP then titrate to effect | IV | Hypertensive emergency | Hypotension, Bradycardia | Beta-blocker and Alpha blocker | Cardiovascular |
65 | Hydralazine | 10-20 mg IVP or IM | IV/IM | Hypertensive emergency | Hypotension, Tachycardia | Vasodilator | Cardiovascular |
66 | Norepinephrine (Levophed) | 2-4 mcg/min and titrate | IV | Sepsis or other causes of shock | Peripheral vasoconstriction, elevated heart rate, hypertension, limb ischemia | Vasopressor | Cardiovascular |
67 | Vasopressin | 0.03 Units/min | IV | Sepsis or other causes of shock | Peripheral vasoconstriction, elevated heart rate, hypertension, limb ischemia | Vasopressor | Cardiovascular |
68 | Diltiazem | 10-20 mg IV then oral drip or PO option | IV/PO | A-Fib Rate control | Hypotension, Bradycardia | Calcium channel blocker | Cardiovascular |
69 | Bumetanide | 1 mg IV/PO | IV/PO | Heart Failure, Edema | Hypotension, electrolyte imbalances | Loop Diuretic | Cardiovascular |
70 | Spironolactone | 25-50 mg PO Daily | PO | Heart Failure, Edema, Ascites | Hypotension, electrolyte imbalances | Aldosterone Antagonist (Potassium Sparing Diuretic) | Cardiovascular |
71 | Mannitol | .25-.5g/kg IV bolus, then infuse | IV | Increased intracranial pressure | Hypotension, electrolyte imbalances | Osmotic diuretic | Neuro |
72 | Diazepam | 5-10mg IV/PO | IV/PO | Seizure, anxiety | Hypotension, respiratory depression | Benzodiazepine | Neuro |
73 | Levetiracetam (Keppra) | 500-1500 mg IV/PO | IV/PO | Seizure prophylaxis/treatment | fatigue, dizziness, confusion | Anticonvulsant | Neuro |
74 | Ceftazidime | 1-2 g IV q8-12 | IV | Gram negative infections, pseudomonas | Headache, Diarrhea | Cephalosporin Antibiotic | Antimicrobial |
75 | Meropenem | 500mg-1g IV Q8 | IV | Severe infections resistant to other antibiotics | Headache, Diarrhea | Carbapenem Antibiotic | Antimicrobial |
76 | Clindamycin | 300-900 mg IV/PO Q6-8 | IV/PO | Gram + infections, anaerobes | Diarrhea, C. Diff | Lincosamide Antibiotic | Antimicrobial |
77 | Fluconazole | 200-400mg IV/PO Daily | IV/PO | Fungal infections, candidiasis, cryptococcus | Headache, Liver enzyme abnormalities | Antifungal | Antimicrobial |
78 | Valacyclovir | 1g PO BID | PO | HSV, Varicella Zoster | Headache, Liver enzyme abnormalities | Antiviral | Antimicrobial |
79 | Oseltamivir (Tamiflu) | 75mg PO BID | PO | Influenza A or B | Headache, Nausea, Vomiting | Antiviral | Antimicrobial |
80 | Trimethoprim/Sulfamethoxazole (Bactrim) | 1-2 Tabs PO BID or IV q12 | IV/PO | UTI, MRSA skin infections, pneumocystis pneumonia | Rash, Photosensitivity | Sulfa Antibiotic | Antimicrobial |
81 | Fidaxomicin (Dificid) | 200 mg PO BID | PO | C. Diff | Nausea Vomiting | Macrolide Antibiotic | GI |
82 | Rifampin | 600 mg PO Daily | PO | TB, prosthetic joint infections | Headache, Liver enzyme abnormalities, Turns bodily fluid orange | Broad spectrum antibiotic | Antimicrobial |
83 | Dexamethasone | 4-8mg IV/PO Q6 | IV/PO | Swelling, inflammation, allergic reactions, Asthma/COPD exacerbation, Nausea | Mood changes, increased blood sugar, immune suppression, Increased appetite | Corticosteroid | Respiratory |
84 | Methylprednisolone | 40-125 mg IV/PO q6 | IV/PO | Swelling, inflammation, allergic reactions, Asthma/COPD exacerbation, Nausea | Mood changes, increased blood sugar, immune suppression, Increased appetite | Corticosteroid | Respiratory |
85 | Haloperidol | 2-5 mg IM/PO q4-8h PRN | IM/PO | Acute psychosis, agitation | Extrapyramidal symptoms (EPS), QTc prolongation, sedation | Dopamine antagonist (typical antipsychotic) | Psychiatric |
86 | Nalbuphine | 10-20 mg IV/IM/SC q3-6 prn | IV/IM/SC | Moderate to severe pain | Sedation, respiratory depression, nausea, vomitting | Opioid partial |
Key Considerations
Documentation is Crucial: Document all assessments, interventions, and patient responses accurately and completely.
Go to Table of Contents Quickly
This comprehensive guide provides a solid foundation in these fundamental nursing concepts. Remember to practice these skills under the supervision of an experienced nurse to gain confidence and competence. Good luck! Let me know if you have any specific questions about any of these topics!
Leave a Reply